Numéros de Téléphone Niolat Julie
Profils Twitter
Profils Myspace
113103-132
Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in ...
http://meetinglibrary.asco.org/content/113103-132
The Lancet Oncology | Vol 15, Iss 13, Pgs …
The Lancet Oncology Volume 15, Issue 13, Pages 1407-1532, e581-e634 (December 2014)
http://www.sciencedirect.com/science/journal/14702045/15
The Lancet Oncology, December 2014, Volume …
REWARD The Lancet REWARD (REduce research Waste And Reward Diligence) Campaign invites all involved in biomedical research to critically examine the research ...
http://www.thelancet.com/journals/lanonc/issue/vol15no13/PIIS1470-2045(14)X7172-X
Everolimus for subependymal giant cell …
In the EXIST-1 trial, initiated on Aug 10, 2009, more than 35% of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis co
http://www.sciencedirect.com/science/article/pii/S1470204514704899
